Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

The reverse split is primarily intended to bring Sharps into compliance with the minimum bid price requirement for ...

In the ensuing years, the pharma supply chain will become even more complex, requiring increasingly agile and responsive logistics to support the development of personalized medicine. Sustainability ...

With extensive experience in manufacturing APIs, advanced intermediates and specialty chemicals, SCI Pharmtech is one of ...

As India speeds up towards digital innovation, blockchain is not just a technology upgrade—it's the move towards ...

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a ...

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...

In what could be seen as a bellwether for the pharmaceutical industry's sweeping shift toward localised manufacturing—spurred ...